Sio Gene Therapies Inc.

NASDAQ:SIOX

0.415 (USD) • At close July 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Operating Activities:
Net Income -4.019-3.08-8.406-13.324-25.456-21.237-11.87-3.331-10.516-9.984-8.594-16.648-14.039-13.884-28.057-9.046-34.296-33.835-51.888-25.319-57.902-69.086-69.266-52.833-47.811-42.252-38.055-29.671-63.355-12.061-28.058
Depreciation & Amortization 0.137-0.1340.2710.250.1940.1120.110.2890.6360.6220.9190.7160.8490.7340.7950.3270.4760.6131.0340.971.0630.7150.3350.2140.0130.0110.0110.006-0.0060.0130.001
Deferred Income Tax 00000-0.0020.002-9.080.0060.348-2.14-0.251-0.3010.552-0.94700000002.70900000-0.0010-0.182
Stock Based Compensation 0.2270.215-0.159-2.5921.3987.2981.3210.9180.8761.1081.592.5572.3120.8732.1533.5554.5582.4575.859-9.70110.63915.3415.68.5418.3317.93711.5618.42839.0562.6222.282
Change In Working Capital -1.133-3.025-0.228-2.0043.4124.616-2.1640.904-2.058-3.471-4.849-4.02-1.348-6.288.343-2.026-3.6373.557-16.9770.492-1.054-8.7075.7612.34210.27711.3097.917-1.9793.619-0.7341.24
Accounts Receivables 000000000.0210000000000000000000000
Change In Inventory 00000000-0.9410000000000000000000000
Change In Accounts Payables -1.762-0.277-1.744-2.6273.9381.736-0.4040.354-1.185-0.798-1.4424.061-1.22-1.3291.1980.68-0.7990.386-2.5182.917-1.828-5.687-0.004-0.7-0.2596.6672.221-2.9342.8590.0660.228
Other Working Capital 0.629-2.7481.5160.623-0.5262.88-1.760.550.047-2.673-3.407-8.081-0.128-4.9517.145-2.706-2.8383.171-14.459-2.4250.774-3.025.7653.04210.5364.6425.6960.9550.76-0.81.012
Other Non Cash Items -0.1340.941-0.159-0.152-0.153-0.054-0.0510.0590.031-0.443-0.429-0.264-0.559-0.741-0.018-5.4860.093-0.1040.559-0.6420.6640.099-3.0580.37800005.25300.182
Operating Cash Flow -4.922-5.083-8.681-17.822-20.605-9.267-12.652-10.241-11.025-11.82-13.503-17.91-13.086-18.746-17.731-12.676-32.806-27.312-61.413-34.2-46.59-61.639-47.919-41.358-29.19-22.995-18.566-23.216-15.434-10.162-4.535
Investing Activities:
Investments In Property Plant And Equipment -0.29-0.013-0.277-0.359-0.142-0.014-0.18-0.151-0.117-0.111-0.019-0.005-0.076-0.096-0.078-0.128-0.056-0.0180-0.038-0.603-1.472-2.1710-0.069-0.008-0.028-0.531-4.778-0.03-0.007
Acquisitions Net 0000000000000000000000000000000
Purchases Of Investments 0000000000000000000000000000000
Sales Maturities Of Investments 0000004.343000000000000000000000000
Other Investing Activites 0.190.190000012.78400000000000000000000000
Investing Cash Flow -0.10.177-0.277-0.359-0.142-0.0144.16312.633-0.117-0.111-0.019-0.005-0.076-0.096-0.078-0.128-0.056-0.0180-0.038-0.603-1.472-2.1710-0.069-0.008-0.028-0.531-4.778-0.03-0.007
Financing Activities:
Debt Repayment 00000000-15.7310-15.7310-19.308-5.208-5.047-4.92700000000000000-0.627
Common Stock Issued 00000.96200.47936.71728.98619.5983.9370.8100037.85531.680000-0.113134.6280000000336.893
Common Stock Repurchased 0000000000000000000000000000000
Dividends Paid 0000000000000000000000000000000
Other Financing Activities 00000000.04215.7350.0220.0530.0450.0270.1290.0331.936-4.60525.1220.010.3240.0710.7390.74753.52600.01-50.001-0.001-0.666-0.655
Financing Cash Flow 00000.96200.47936.75928.9919.62-11.74870.855-19.281-5.079-5.01434.86427.07525.1220.010.3240.0710.626135.37553.52600.01-50.001-0.001-0.666335.611
Other Information:
Effect Of Forex Changes On Cash 00000000-17.581000000000000000000-0.001004.542
Net Change In Cash -4.922-4.906-8.958-16.997-19.785-10.465-8.0139.15117.8487.689-25.2752.94-32.443-23.921-22.82322.06-5.787-2.208-61.403-33.914-47.122-62.48585.28512.168-29.259-22.993-23.594-23.747-20.213-10.858335.611
Cash At End Of Period 46.12751.04955.95564.91381.91101.695112.16120.1781.01963.17155.48280.75227.81260.25584.176106.99984.93990.72692.934154.337188.251235.373297.858212.573200.405229.664252.657276.251299.998320.211331.069